活細胞成像市場規模、佔有率、成長分析、按產品和服務、按應用、按技術、按最終用戶、按地區 - 產業預測，2024-2031年

2022年全球活細胞成像市場規模為23億美元，預測期內（2024-2031年）年複合成長率為8.2%，預計將從2023年的24.9億美元增加至2031年的46.7億美元。

由於成像技術投資的增加以及細胞研發需求的迅速增加，預計活細胞成像市場在未來幾年將顯著成長。特別是，活細胞成像在腫瘤學研究中的應用引起人們的關注，而針對幹細胞研究的大量資金預計將進一步增加該領域的需求。隨著全球藥物發現和開發活動的擴大，以及政府資助和細胞治療應用的增加，對活細胞成像的需求也預計會相應增加。此外，人工智慧和機器學習的整合已成為活細胞成像公司尋求在研究期間及之後獲得市場佔有率和創新的主要趨勢。然而，該市場面臨相當大的挑戰，包括缺乏標準化、營運成本高、操作複雜性等，可能會阻礙其長期發展。總體而言，活細胞成像市場提供了由技術進步和對醫療保健中細胞應用的日益關注所驅動的機會，而持續的行業挑戰使其無法充分發揮其潛力，這需要戰略導航。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 依細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 課題
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 價值鏈分析
• 專利分析
• 技術分析
• 監管分析

活細胞影像市場：依產品/服務分類

• 市場概況
• 裝置
  • 顯微鏡
  • 獨立系統
  • 細胞分析儀
  • 配件
• 消耗品
  • 試劑
  • 檢測試劑套件
  • 媒體
  • 其他消耗品
• 軟體
• 服務

活細胞影像市場：依應用分類

• 市場概況
• 細胞生物學
• 發育生物學
• 幹細胞和藥物發現
• 其他

活細胞影像市場：依技術分類

• 市場概況
• 延時顯微鏡
• 光漂白後的螢光恢復（FRAP）
• 螢光共振能量轉移（FRET）
• 高內涵篩檢（HCS）
• 其他

活細胞成像市場：依最終用戶分類

• 市場概況
• 製藥和生物技術公司
• 學術研究所
• 合約調查機構

活細胞成像市場：依地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東、非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Thermo Fisher Scientific
• Danaher Corporation
• PerkinElmer, Inc.
• Carl Zeiss AG
• Nikon Corporation
• Olympus Corporation
• Bruker Corporation
• GE HealthCare
• Becton, Dickinson & Company
• Sartorius AG
• BioTek Instruments（Agilent）
• CytoSMART Technologies
• Oxford Instruments Andor Ltd
• Live Cell Imaging, Inc.
• Olympus Life Science
• Tecan Group
• Cytena GmbH（BICO）
• Merck KGaA

Global Live Cell Imaging Market was valued at USD 2.3 Billion in 2022 and is expected to rise from USD 2.49 Billion in 2023 to USD 4.67 Billion by 2031, at a CAGR of 8.2% during the forecast period (2024-2031).

The live cell imaging market is poised for significant growth in the coming years, driven by increasing investments in imaging technologies and a surging demand for cell research and development. A particular focus on utilizing live cell imaging in oncology research and substantial funding directed towards stem cell research are expected to further enhance demand in this sector. As global activities in drug discovery and development expand, alongside supportive government funding and an uptick in cell therapy applications, the demand for live cell imaging is anticipated to rise correspondingly. Additionally, the integration of artificial intelligence and machine learning is emerging as a crucial trend among live cell imaging companies aiming to innovate and capture market share throughout the study period and beyond. However, the market does face considerable challenges, including a lack of standardization, high operational costs, and complexities associated with operations, which may hinder its long-term development. Overall, while the live cell imaging market presents exciting opportunities fueled by technological advancements and increased focus on cellular applications in healthcare, ongoing industry challenges will require strategic navigation to fully realize its potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Live Cell Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Live Cell Imaging Market Segmental Analysis

Global Live Cell Imaging Market is segmented by Product & Service, Application, Technology, End User and Region. Based on Product & Service, the market is segmented into Instruments (Microscopes, Standalone Systems, Cell Analyzers, Accessories), Consumables (Reagents, Assay Kits, Media, Other Consumables), Software, Services. Based on Application, the market is segmented into Cell Biology, Developmental Biology, Stem Cell & Drug Discovery, and Others. Based on Technology, the market is segmented into Time lapse Microscopy, Fluorescence recovery after photobleaching (FRAP), Fluorescence resonance energy transfer (FRET), High content screening (HCS), and Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Live Cell Imaging Market

The surging focus of healthcare researchers on unlocking the intricate functionalities of cells is a significant market driver for the Global Live Cell Imaging market. As researchers aim to delve deeper into cellular behaviors, the demand for advanced cell-based technologies and products, particularly live cell imaging solutions, has escalated dramatically. This need is further amplified by the increasing recognition of the critical role that real-time observation of live cells plays in enhancing drug development, toxicology studies, and disease research. As innovation in imaging technologies progresses, the future landscape is set for robust growth, firmly establishing live cell imaging as an essential tool in cellular research.

Restraints in the Global Live Cell Imaging Market

One significant market restraint for the Global Live Cell Imaging market is the high cost associated with the development and procurement of advanced live cell imaging equipment and products. The intricate and sophisticated technologies involved in this field translate into substantial expenses for both the equipment and the consumables required for their operation. Consequently, research institutions operating under constrained budgets may find it challenging to invest in such high-end imaging solutions. This financial limitation can hinder the widespread adoption of live cell imaging techniques, ultimately restricting innovation and advancements within the research community and slowing overall market growth.

Market Trends of the Global Live Cell Imaging Market

The Global Live Cell Imaging market is witnessing a notable trend towards the adoption of advanced imaging technologies, particularly 3D and 4D imaging. As researchers seek deeper insights into cellular dynamics and interactions, the integration of these sophisticated imaging modalities is expected to significantly enhance the scope of live cell applications. This shift not only improves understanding of cellular structures but also facilitates real-time monitoring of biological processes. Consequently, companies in the live cell imaging sector are poised to leverage these advancements, driving innovation and expanding market potential as they cater to the evolving demands of the life sciences and biotechnology fields.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Patent Analysis
• Technology Analysis
• Regulatory Analysis

Live Cell Imaging Market, By Product & Service

• Market Overview
• Instruments
  • Microscopes
  • Standalone Systems
  • Cell Analyzers
  • Accessories
• Consumables
  • Reagents
  • Assay Kits
  • Media
  • Other Consumables
• Software
• Services

Live Cell Imaging Market, By Application

• Market Overview
• Cell Biology
• Developmental Biology
• Stem Cell & Drug Discovery
• Others

Live Cell Imaging Market, By Technology

• Market Overview
• Time lapse Microscopy
• Fluorescence recovery after photobleaching (FRAP)
• Fluorescence resonance energy transfer (FRET)
• High content screening (HCS)
• Others

Live Cell Imaging Market, By End User

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations

Live Cell Imaging Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikon Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson & Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTek Instruments (Agilent)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CytoSMART Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Instruments Andor Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Live Cell Imaging, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Life Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytena GmbH (BICO)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments